Skip to content
Screener

CorMedix CRMD Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
IAR
Integra LifeSciencesIART
3.6×+2.4×
ICU Medical logo
ICU MedicalICUI
2.4×0.0×
TFX
TeleflexTFX
2.6×+0.2×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$583.68M-22.4%
P/E3.2×
P/S1.5×-4.7×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on the most recent quarter.

The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 8:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001410098-26-000021

FAQ

What is CorMedix's current ratio?
CorMedix (CRMD) reported current ratio of 3× in Q1 2026.
How has CorMedix's current ratio changed year-over-year?
CorMedix's current ratio decreased by 29.4% year-over-year, from 4.2× to 3×.
What is the long-term trend for CorMedix's current ratio?
Over 5 years (2020 to 2025), CorMedix's current ratio has grown at a -28.9% compound annual growth rate (CAGR), from 11.6× to 2.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about CorMedix's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude